However, a germline protein-truncating variant of CHEK2, 1100delC, was first identified in a patient with breast and colorectal cancer from a family with Li Fraumeni-like syndrome (Bell et al, 1999; Miller et al, 2002). Here, CHEK2 is linked to colorectal cancer.